Albatroz Therapeutics
  • Home
  • Science
  • About
  • News

ALBATROZ THERAPEUTICS FEATURED IN A * STAR RESEARCH HIGHLIGHTS

6/4/2021

 
The solid cancer targeting technology of Albatroz Therapeutics has been featured in A * STAR Research Highlights.
The therapeutic approach is based on the novel discovery by the A * STAR lab of Abatroz's scientific founder Dr.  Frederic Bard  that glycosylation-driven extracellular matrix degradation is essential for tumor growth.

Comments are closed.
© Albatroz Therapeutics Pte. Ltd.
21 Biopolis Rd, #02-03 Nucleos North Tower, Singapore 138567


Terms of Use
  • Home
  • Science
  • About
  • News